Mineralogical analysis and exploration of asbestos diseases;Analyse mineralogique et exploration des pathologies asbestosiques

Revue des Maladies Respiratoires

Volumn 15, Issue 2, 1998, Pages 141-149

  Pairon, J Cl ^a,b   Martinon, L ^b   Brochard, P ^b,c  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b Laboratoire d'Etude des Particules Inhalees   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Asbestos; Asbestos bodies; Lung cancer; Mineralogical analysis

Indexed keywords

ASBESTOSIS; CANCER RISK; FRANCE; HUMAN; LUNG CANCER; LUNG LAVAGE; OCCUPATIONAL EXPOSURE; QUANTITATIVE DIAGNOSIS; REVIEW; CHEMISTRY; ELECTRON MICROSCOPY; LUNG; LUNG FIBROSIS; LUNG TUMOR; MICROSCOPY; PATHOLOGY; QUESTIONNAIRE; REFERENCE VALUE; SPUTUM;

ASBESTOS; MINERAL FIBER;

ASBESTOS; ASBESTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; LUNG; LUNG NEOPLASMS; MICROSCOPY; MICROSCOPY, ELECTRON; MINERAL FIBERS; OCCUPATIONAL EXPOSURE; PULMONARY FIBROSIS; QUESTIONNAIRES; REFERENCE VALUES; SPUTUM;

EID: 0031925140     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. SÉBASTIEN P, JANSON X, GAUDICHET A, HIRSCH A, BIGNON J : Asbestos retention in human respiratory tissues : comparative measurements in lung parenchyma and in parietal pleura. In: Wagner JC, ed. Biological effects of mineral fibres. IARC Sci Publ 1980; 237-46.
2. BOUTIN C, DUMORTIER P, REY F, VIALLAT JR, DE VUYST P : Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med 1996;153:444-9.
3. CHURG A, WARNOCK ML : Asbestos and other ferruginous bodies : their formation and clinical significance. Am J Pathol 1981;102:447-56.
4. SÉBASTIEN P, ARMSTRONG B, MONCHAUX G, BIGNON J : Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis 1988;137:75-8.
5. KARJALAINEN A, PLIPARI R, MÄNTYLÄ T, MÖNKKÖNEN M, NURMINEN M, TUKIAINEN P, VANHALA E, ANTTILA S : Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibres in lung parenchyma. Eur Respir J 1996;9:1000-5.
6. TESCHLER H, THOMPSON AB, DOLLENKAMP R, KONIETZKO N, COSTABEL U : Relevance of asbestos bodies in sputum. Eur Respir J 1996;9:680-6.
7. CHURG A : The distribution of amosite asbestos in the periphery of the normal human lung. Br J Ind Med 1990;47:677-81.
8. DODSON RF, GREENBERG D, WILLIAMS MG, CORN CJ, O'SULLIVAN MF, HURST GA : Asbestos content in lungs of occupationally and nonoccupationally exposed individuals. JAMA 1984;252:68-71.
9. MORGAN A, HOLMES A : The distribution and characteristics of asbestos fibers in the lungs of Finnish anthophyllite mine workers. Environ Res 1984; 33:62-15.
10. SÉBASTIEN P, FONDIMARE A, BIGNON J, MONCHAUX G, DESBORDES J, BONNAUD G : Topographic distribution of asbestos fibres in human lung in relation to occupational and non-occupational exposure. In: Walton WH, ed. Inhaled Particles IV. Oxford : Pergamon Press, 1977:435-44.
11. TESCHLER H, KONIETZKO N, SCHOENFELD B, RAMIN C, SCHRAPS T, COSTABEL U : Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. Am Rev Respir Dis 1993;147:1211-5.
12. GIBBS AR, STEPHENS M, GRIFFITHS DM, BLIGHT BJN, POOLEY FD : Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. Br J Ind Med 1991;48:162-10.
13. ROGGLI VL: Asbestos bodies and nonasbestos ferruginous bodies. In : Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of asbestos-associated diseases. Boston : Little, Brown and Co, 1992:39-75.
14. MURAI Y, KITAGAWA M, HIRAOKA T : Asbestos body formation in the human lung: distinctions, by type and size. Arch Environ Health 1995;50:19-25.
15. SÉBASTIEN P, BÉGIN R, CASE BW, MCDONALD JC : Inhalation of chrysotile dust. In: Wagner JC ed. The biological effects of chrysotile. Philadelphia: Lippincott, 1986:19-29.
16. DE KLERK NH, MUSK AW, WILLIAMS V, FILION PR, WHITAKER D, SHILKIN KB : Comparison of measures of exposure to asbestos in former crocidolite workers from Wittenoom Gorge, Western Australia. Am J Ind Med 1996;30:579-87.
17. GIBBS AR, POOLEY FD : Analysis and interpretation of inorganic mineral particles in lung tissue. Thorax 1996;51:327-34.
18. DE VUYST P, DUMORTIER P, SWAEN GMH, PAIRON JC, BROCHARD P : Respiratory health effects of man-made vitreous (mineral) fibres. Eur Respir J 1995;8:2149-73.
19. GYLSETH B, BAUNAN RH, OVERAAE L : Analysis of fibres in human lung tissue. Br J Ind Med 1982;39:191-5.
20. GYLSETH B, CHURG A, DAVIS JMG et al. : Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial. Scand J Work Environ Health 1985;11:107-10.
21. GAUDICHET A, JANSON X, MONCHAUX G et al. : Assessment by analytical microscopy of the total lung fibre burden in mesothelioma patients matched with four other pathological series. Ann Occup Hyg 1988;32:213-23.
22. CASE BW, SÉBASTIEN P, MCDONALD JC : Analysis in accident victims: a biological assessment of general environmental exposures. Arch Environ Health 1988;43:178-9.
23. ARENAS-HUERTERO FJ, SALAZAR-FLORES M, OSORNIO-VARGAS AR : Ferruginous bodies as markers of environmental exposure to inorganic particles: experience with 270 autopsy cases in Mexico. Environ Res 1994; 64:10-7.
24. MOLLO F, PIRA E, PIOLATTO G et al. : Lung adenocarcinoma and indicators of asbestos exposure. Int J Cancer 1995; 60:289-93.
25. MONSO E, TEXIDO A, LOPEZ D et al. : Asbestos bodies in normal lung of western mediterranean populations with no occupational exposure to inorganic dust. Arch Environ Health 1995;50:305-11.
26. DUFRESNE A, BÉGIN R, CHURG A, MASSÉ F : Mineral fiber content of lung in patients with mesothelioma seeking compensation in Quebec. Am J Respir Crit Care Med 1996; 153:711-8.
27. KARJALAINEN A, NURMINEN M, VANHALA E, VAINIO H, ANTTILA S : Pulmonary asbestos bodies and asbestos fibers as indicators of exposure. Scand J Work Environ Health 1996;22:34-8.
28. TUOMI T, HUUSKONEN MS, TAMMILEHTO L, VANHALA E, VIRTAMO M : Occupational exposure to asbestos as evaluated from work histories and analysis of lung tissues from patients with mesothelioma. Br J Ind Med 1991;48:48-52.
29. ROGGLI VL : Malignant mesothelioma and duration of asbestos exposure: correlation with tissue mineral fibre content. Ann Occup Hyg 1995;39:363-74.
30. DE VUYST P, DUMORTIER P, MOULIN E, YOURASSOWSKY N, YERNAULT JC : Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 1987;136:1219-24.
31. CHURG A, VEDAL S : Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med 1994; 150:663-9.
32. BECKLAKE MR, CASE BW : Fiber burden and asbestos-related lung disease: determinants of dose-response relationships. Am J Respir Crit Care Med 1994;150:1488-92.
33. ROGGLI VL, PRATT PC, BRODY AR : Analysis of tissue mineral fiber content. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of asbestos-associated diseases. Boston: Little, Brown and Co, 1992:299-345.
34. ORLOWSKI E, PAIRON JC, AMEILLE J et al. : Pleural plaques, asbestos exposure and asbestos bodies in bronchoalveolar lavage fluid. Am J Ind Med 1994;26:349-58.
35. VOISIN C, FISEKCI F, VOISIN-SALTIEL S, AMEILLE J, BROCHARD P, PAIRON JC : Asbestos-related rounded atelectasis: radiologic and mineralogic data in 23 cases. Chest 1995; 107:477-81.
36. GIBBS AR, JONES JSP, POOLEY FD, GRIFFITHS DM, WAGNER JC : Non-occupational malignant mesothelioma. In: Bignon J, Peto J, Saracci R, eds. Non-occupational exposure to mineral fibres. Lyon : IARC Scientif Publ No 90, 1989:219-28.
37. MCDONALD JC, ARMSTRONG B, CASE B et al. : Mesothelioma and fiber type. Evidence from lung tissue analyses. Cancer 1989;63:1544-7.
38. ROGERS AJ, LEIGH J, BERRY G, FERGUSON A, MULDER HB, ACKAD M : Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma. Cancer 1991;67:1912-20.
39. PAIRON JC, ORLOWSKI E, IWATSUBO Y et al. : Pleural mesothelioma and exposure to asbestos : evaluation from work histories and analysis of asbestos bodies in bronchoalveolar lavage fluid or lung tissue in 131 patients. Occup Environ Med 1994;51:244-9.
40. CHURG A, WRIGHT JL, VEDAL S : Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. Am Rev Respir Dis 1993;148:25-31.
41. KARJALAINEN A, ANTTILA S, VANHALA E, VAINIO H : Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 1994;20:243-50.
42. PAIRON JC, BILLON-GALLAND MA, IWATSUBO Y et al. : Lung retention of asbestos in lung cancer. European Respiratory Society, Stockholm, Sept 7-11 1996. Eur Respir J 1996; 9 (Suppl23):248S (abstract)
43. PAIRON JC, MARTINON L, IWATSUBO Y, VALLENTIN F, BILLON-GALLAND MA, BROCHARD P : Retention of asbestos bodies in the lung of welders. Am J Ind Med 1994;25:793-804.
44. DÉCRET No 96-445 du 22 mai 1996 modifiant et complétant les tableaux de maladies professionnelles annexés au livre IV du code de la Sécurité sociale (deuxième partie : Décrets en Conseil d'Etat). JORF, 25 mai 1996:7805-7.
45. KARJALAINEN A, ANTTILA S, MÄNTYLA T, TASKINEN E, KYYRÖNEN P, TUKIAINEN P : Asbestos bodies in bronchoalveolar lavage fluid in relation to occupational history. Am J Ind Med 1994;26:645-54.
46. PAIRON JC, BROCHARD P, BIGNON J : Pathologies respiratoires liées à l'inhalation de fibres industrielles. In: Aubier M, Fournier M, Pariente R, eds. Traité de Pneumologie. Paris : Flammarion, 1996:789-98.